ACP Journal Club. Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease

Ann Intern Med. 2013 Jul 16;159(2):JC3. doi: 10.7326/0003-4819-159-2-201307160-02003.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Coronary Disease / drug therapy*
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Female
  • Heptanoic Acids / administration & dosage*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Male
  • Pyrroles / administration & dosage*
  • Simvastatin / administration & dosage*

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Simvastatin